EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Host Immune Response in Chronic Hepatitis Delta: Implications for Pathogenesis and Therapy

Arshi Khanam iD, Abutaleb Ameer, Poonam Mathur iD, Cihan Yurdaydin iD, Shyam Kottilil iD

Pathogens · 21.08.2025 · 14 (8) · 828

DOI: 10.3390/pathogens14080828 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 21.08.2025. Verfasst von Arshi Khanam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Hauptthemen laut MEDLINE: Hepatitis D, Chronic, Hepatitis Delta Virus, Host-Pathogen Interactions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: division of clinical care and research departmental funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hepatitis delta (CHD) represents the most severe form of viral hepatitis due to rapid disease progression towards liver cancer, leading to high morbidity and mortality. Hepatitis delta virus (HDV) can only infect individuals who are infected with hepatitis B. So far, there is no cure or vaccine for HDV. Existing treatment options, including pegylated interferon-α and hepatocyte entry inhibitors, offer limited efficacy. Emerging therapeutic strategies are focused on targeting various steps of the HDV life cycle or enhancing the host immune response to promote viral elimination. A defective antiviral immune response is increasingly recognized as a culprit for HDV persistence; however, the precise immunological mechanism associated with disease progression and pathogenesis has not been well defined. This review provides an update on the current understanding of host immune response in CHD, highlighting its role in both disease pathogenesis and viral clearance. A deeper understanding of these immune correlates may lead the way to novel treatment strategies, including immunotherapies targeting host immune response that can be used in combination with other antiviral therapies to achieve more effective and durable treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis D, ChronicHepatitis Delta VirusHost-Pathogen InteractionsHumansAntiviral AgentsImmunotherapyAnimals

Stichwörter der Autor:innen

chronic hepatitis deltacirrhosishepatocellular carcinomahost immune response

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Department of Surgery, George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.
  • Department of Gastroenterology & Hepatology, Koç University School of Medicine, Istanbul 34450, Turkey.

ORCID-Profile: Arshi Khanam, Poonam Mathur, Cihan Yurdaydin, Shyam Kottilil

Förderung

  • division of clinical care and research departmental funds

Zitieren

APA

Khanam, A., Ameer, A., Mathur, P., Yurdaydin, C., & Kottilil, S. (2025). Host Immune Response in Chronic Hepatitis Delta: Implications for Pathogenesis and Therapy. Pathogens, 14(8), 828. https://doi.org/10.3390/pathogens14080828

Vancouver

Khanam A, Ameer A, Mathur P, Yurdaydin C, Kottilil S. Host Immune Response in Chronic Hepatitis Delta: Implications for Pathogenesis and Therapy. Pathogens. 2025;14(8):828. doi:10.3390/pathogens14080828

BibTeX
@article{Khanam2025,
  author = {Khanam, Arshi and Ameer, Abutaleb and Mathur, Poonam and Yurdaydin, Cihan and Kottilil, Shyam},
  title = {Host Immune Response in Chronic Hepatitis Delta: Implications for Pathogenesis and Therapy},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {8},
  pages = {828},
  doi = {10.3390/pathogens14080828}
}
Kostenlos starten →